These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28170403)

  • 21. Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta.
    Wagner MJ; Dimitrov M; Lam GY; Leung W; Tyrrell GJ; Vethanayagam D
    PLoS One; 2023; 18(7):e0288704. PubMed ID: 37450508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
    Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
    Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Wilson CB; Jones PW; O'Leary CJ; Hansell DM; Cole PJ; Wilson R
    Eur Respir J; 1997 Aug; 10(8):1754-60. PubMed ID: 9272915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
    Mac Aogáin M; Ivan FX; Jaggi TK; Richardson H; Shoemark A; Narayana JK; Dicker AJ; Koh MS; Lee KCH; Thun How O; Poh ME; Chin KK; Hou ALY; Ser Hon P; Low TB; Abisheganaden JA; Dimakou K; Digalaki A; Kosti C; Gkousiou A; Hansbro PM; Blasi F; Aliberti S; Chalmers JD; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Jul; 210(1):47-62. PubMed ID: 38271608
    [No Abstract]   [Full Text] [Related]  

  • 25. Respiratory Pathogens at Exacerbation in Chronic Bronchitis With Airway Bacterial Colonisation: A Cohort Study.
    Jones TL; Roberts C; Elliott S; Glaysher S; Green B; Shute JK; Chauhan AJ
    Clin Respir J; 2024 Aug; 18(8):e13811. PubMed ID: 39162176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Airway inflammation and etiology of acute exacerbations of chronic bronchitis.
    Sethi S; Muscarella K; Evans N; Klingman KL; Grant BJ; Murphy TF
    Chest; 2000 Dec; 118(6):1557-65. PubMed ID: 11115440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome.
    Woo TE; Lim R; Heirali AA; Acosta N; Rabin HR; Mody CH; Somayaji R; Surette MG; Sibley CD; Storey DG; Parkins MD
    Sci Rep; 2019 May; 9(1):6871. PubMed ID: 31053725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic Fibrosis Patients Infected With Epidemic
    Acosta N; Waddell B; Heirali A; Somayaji R; Surette MG; Workentine ML; Rabin HR; Parkins MD
    Front Cell Infect Microbiol; 2020; 10():173. PubMed ID: 32426295
    [No Abstract]   [Full Text] [Related]  

  • 29. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
    Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
    Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three clinically distinct chronic pediatric airway infections share a common core microbiota.
    van der Gast CJ; Cuthbertson L; Rogers GB; Pope C; Marsh RL; Redding GJ; Bruce KD; Chang AB; Hoffman LR
    Ann Am Thorac Soc; 2014 Sep; 11(7):1039-48. PubMed ID: 24597615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
    Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymicrobial airway bacterial communities in adult bronchiectasis patients.
    Purcell P; Jary H; Perry A; Perry JD; Stewart CJ; Nelson A; Lanyon C; Smith DL; Cummings SP; De Soyza A
    BMC Microbiol; 2014 May; 14():130. PubMed ID: 24886473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.
    Weiser R; Rye PD; Mahenthiralingam E
    J Microbiol Methods; 2021 Feb; 181():106133. PubMed ID: 33421446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predominant pathogen competition and core microbiota divergence in chronic airway infection.
    Rogers GB; van der Gast CJ; Serisier DJ
    ISME J; 2015 Jan; 9(1):217-25. PubMed ID: 25036925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway microbiota is associated with the severity of non-CF bronchiectasis.
    Li L; Zhang J; Li Z; Zhang C; Bi J; Zhou J; Song Y; Shao C
    Clin Respir J; 2021 Feb; 15(2):154-162. PubMed ID: 32966701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
    Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.